Personal record-keeping and educational reference. 18+. The app does not recommend substances, doses or treatment, or determine whether a substance is safe, approved or appropriate for you. Consult a qualified healthcare professional about decisions involving your health.
‹ Library

Tesamorelin + Ipamorelin Blend

Blend & StackResearch Use Only

Also known as: Tesa + Ipa Blend

A belly-fat-focused GH blend — tesamorelin's visceral-fat evidence plus ipamorelin's clean GH pulse.

Dosing quick reference

research reference
Starting dose
375 mcg once daily (250 tesa + 125 ipa)
Frequency
Once daily
Typical range
Up to 2 mg tesa + 1 mg ipa per day
Cycle
8–16 weeks
Titration (step-up)
Step up every 2 weeks toward 1.5–2 mg tesamorelin by week 7+
Half-life
Varies by component
Route
Subcutaneous (research)
Common use
Growth-hormone axis and body-composition research
Common vial sizes
10 mg total
Storage
Refrigerate reconstituted solution at 2-8 C; keep powder cold until reconstitution.
Stacking notes
Components: Tesamorelin, Ipamorelin.

Reported side effects

Injection-site irritationFluid retention reported anecdotallyJoint discomfort reported anecdotallyHuman data limited
Regulatory note: Tesamorelin is an approved prescription drug in some jurisdictions, including Canada; a component of this blend is therefore a regulated pharmaceutical.
Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.